Cargando…

Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study

BACKGROUND: Antibiotic prophylaxis is recommended during ANCA-associated vasculitis (AAV) induction. We aimed to describe the frequency, persistence, and factors associated with trimethoprim-sulfamethoxazole (TMP-SMX) use in an adult population sample with granulomatosis with polyangiitis (GPA) trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendel, Arielle, Behlouli, Hassan, de Moura, Cristiano Soares, Vinet, Évelyne, Curtis, Jeffrey R., Bernatsky, Sasha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386686/ https://www.ncbi.nlm.nih.gov/pubmed/37516897 http://dx.doi.org/10.1186/s13075-023-03114-7

Ejemplares similares

Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab
por: Geetha, Duvuru, et al.
Publicado: (2014)

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
por: Shah, Shivani, et al.
Publicado: (2015)

Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
por: Merkel, Peter A., et al.
Publicado: (2021)

Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2018)

Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis
por: Endo, Yushiro, et al.
Publicado: (2018)

Methemoglobinemia in a Pediatric Oncology Patient Receiving Sulfamethoxazole/Trimethoprim Prophylaxis
por: Carroll, Timothy G., et al.
Publicado: (2016)

1592. Safety of Oral Trimethoprim/Sulfamethoxazole Prophylaxis in Renal Transplant Recipients
por: Horvat, Courtney, et al.
Publicado: (2018)

Efficacy of using trimethoprim‐sulfamethoxazole prophylaxis in an adult patient with autoimmune neutropenia
por: Azuma, Naoto, et al.
Publicado: (2019)

Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
por: Hudzik, Samantha A., et al.
Publicado: (2020)

Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator
por: Kwon, Hyeok Chan, et al.
Publicado: (2020)

Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies
por: Nakazawa, Maho, et al.
Publicado: (2018)

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
por: Teixeira, Vítor, et al.
Publicado: (2019)

Activation of natural killer cells by rituximab in granulomatosis with polyangiitis
por: Urlaub, Doris, et al.
Publicado: (2019)

Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
por: Dance, D.A.B., et al.
Publicado: (2014)

Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study
por: Mendel, Arielle, et al.
Publicado: (2023)

Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant
por: Chapman, Fiona A., et al.
Publicado: (2019)

Eosinophilic granulomatosis with polyangiitis with severe pulmonary hemorrhage treated with rituximab
por: Baikunje, S., et al.
Publicado: (2016)

Successful Treatment with Rituximab for Granulomatosis with Polyangiitis and Multiple Cranial Neuropathies
por: Horiuchi, Kazuhiro, et al.
Publicado: (2020)

Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis
por: Puéchal, Xavier, et al.
Publicado: (2022)

Rituximab-Induced Colitis and Esophagitis in a Patient With Granulomatosis With Polyangiitis
por: Boateng, William K, et al.
Publicado: (2023)

Myocarditis after Trimethoprim/Sulfamethoxazole Treatment for Ehrlichiosis
por: Nayak, Seema U., et al.
Publicado: (2013)

Life-Threatening Thrombocytopenia Secondary to Trimethoprim/Sulfamethoxazole
por: Gaudel, Pramod, et al.
Publicado: (2017)

Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline
por: Long, Clara Y, et al.
Publicado: (2021)

Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients
por: Goto, Norihiko, et al.
Publicado: (2017)

Determinants of Malaria Protective Immunity in Mice Immunized with Live Sporozoites during Trimethoprim–Sulfamethoxazole Prophylaxis
por: Hobbs, Charlotte V., et al.
Publicado: (2021)

Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis
por: Besada, Emilio, et al.
Publicado: (2015)

Concurrent Use of Mepolizumab and Rituximab for Eosinophilic Granulomatosis With Polyangiitis and Multisystem Involvement
por: Afiari, Agura, et al.
Publicado: (2020)

Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi
por: Adachi, Sei, et al.
Publicado: (2022)

Antiphospholipid Antibody Testing in a General Population Sample from the USA: An Administrative Database Study
por: Egiziano, Giordano, et al.
Publicado: (2020)

Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis
por: Brogan, Paul, et al.
Publicado: (2021)

Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis
por: Jamois, Candice, et al.
Publicado: (2022)

Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
por: Prasad, G. V. Ramesh, et al.
Publicado: (2019)

Stenotrophomonas maltophilia resistant to trimethoprim – sulfamethoxazole: an increasing problem
por: Al-Jasser, Asma Marzouq
Publicado: (2006)

Fixed Drug Eruption of the Penis Secondary to Sulfamethoxazole-Trimethoprim
por: Lawrentschuk, Nathan, et al.
Publicado: (2006)

A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole
por: Hamid, Mohsin, et al.
Publicado: (2018)

Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole
por: Minato, Yusuke, et al.
Publicado: (2018)

Intravitreal Trimethoprim and Sulfamethoxazole Toxicity to the Retina of Albino Rabbits
por: Mazza, Orit, et al.
Publicado: (2018)

Analysis of the Clinical Characteristics of Hyponatremia Induced by Trimethoprim/Sulfamethoxazole
por: Lei, Haibo, et al.
Publicado: (2022)

The Risk of Emerging Resistance to Trimethoprim/Sulfamethoxazole in Staphylococcus aureus
por: Sato, Takumi, et al.
Publicado: (2022)

Severe hyponatremia due to trimethoprim-sulfamethoxazole-induced SIADH
por: Marak, Creticus, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s0hpqmi4nfkb96hujo28b17gag